Why this trial matters: First triple hormone receptor agonist showing major Phase III weight-loss efficacy Delivers weight-loss outcomes far beyond many current therapies Suggests a potential new metabolic and obesity care benchmark Semaglutide Shows Consistent Liver Benefits in MASH In the Phase III ESSENCE study, once-weekly semaglutide 2.4 mg significantly increased rates of steatohepatitis resolution and fibrosis improvement on liver biopsy in adults with metabolic dysfunction-associated steatohepatitis (MASH), compared with placebo
They offer practical advantages when studying therapeutic uses and potential side effects of MT-2 in areas including sunless tanning and sexual desire
doi: 10.3748/wjg.v20.i47.17756 67
Lifestyle Integration Daily habits shift baseline biology and set the stage for how well peptides perform
Powered by Vitamin C + Glutathione, Retinal + Peptides, and a Cooling Hydrogel Eye Mask, this trio delivers round-the-clock clarity, renewal, and targeted care for areas that need extra attention
It may also be an option for those seeking a more efficient way to support overall wellness, including skin health